PA
SLXP

Profund Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Profund Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-16,675
Closed -$2.88M – 1572
2015
Q1 		$2.88M Buy
16,675
+3,113
+23% +$457K 0.11% 128
2014
Q4 		$1.56M Buy
13,562
+2,443
+22% +$296K 0.06% 268
2014
Q3 		$1.74M Sell
11,119
-1,542
-12% -$224K 0.08% 218
2014
Q2 		$1.56M Sell
12,661
-2,706
-18% -$299K 0.07% 294
2014
Q1 		$1.59M Buy
15,367
+1,299
+9% +$133K 0.07% 247
2013
Q4 		$1.26M Buy
14,068
+1,036
+8% +$82.6K 0.06% 370
2013
Q3 		$872K Buy
13,032
+1,682
+15% +$116K 0.05% 523
2013
Q2 		$751K Buy
+11,350
New +$649K 0.05% 391

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Profund Advisors's SLXP Position: Q2 2015 in Review

Profund Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 16,675 shares — an estimated $2.88M sold.

Profund Advisors first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $2.88M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Profund Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Profund Advisors sold 16,675 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $2.88M.
  • Profund Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Profund Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $2.88M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Profund Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.